Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
By J. Katzmann, R. Clark, R. Abraham, S. Bryant, J. Lymp, A. Bradwell, R. Kyle. 2002
657 citations recorded by the source corpus.
Subfields: Hematology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/f77508bfc58f498d92c23477b980926d89e9c58b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
In Molecular Biology
Citations in the corpus
- Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group (2003, background): “This is particularly relevant in patients with non-secretory myeloma, solitary plasmacytoma or primary systemic amyloidosis (Drayson et al, 2001; Katzmann et al, 2002).”
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis (2005, background): “Patients without a quantifiableM component are the ones in whom the serum-free light chain measurement is the most valuable [98].”